Brief: Onxeo Publishes Cash Position Of 11.3 Million Euros At Year End

Valerio Therapeutics SA

12/03/2019 17:15

March 12 (Reuters) - Onxeo SA  C4X.PA :
    * CASH POSITION OF EUR 11.3 MILLION AT DECEMBER 31, 2018 AND
NEW
EQUITY FINANCING NEGOTIATED TO ENSURE CASH RUNWAY INTO Q2 2020
    * FY NET LOSS EUR 9.4 MILLION VERSUS LOSS OF EUR 59.1
MILLION YEAR
AGO
    * FY OPERATING LOSS EUR 3.5 MILLION VERSUS LOSS OF EUR 19.2
MILLION YEAR AGO
    * FY REVENUE EUR 6.1 MILLION VERSUS EUR 9.5 MILLION YEAR AGO
    * CLINICAL DEVELOPMENT OF ASIDNA CONTINUES IN PHASE 1 STUDY
DRIIV-1
    * NEW LEAD COMPOUND SOURCED FROM PLATON READY TO ENTER
PRECLINICAL
PROOF-OF-CONCEPT STUDIES
    * IMPENDING INITIATION OF A PHASE 1B STUDY IN COMBINATION
WITH
PLATINUM-BASED CHEMOTHERAPY AND PACLITAXEL; PRELIMINARY RESULTS
EXPECTED BEFORE YEAR-END 2019

Source text for Eikon:  ID:nBw8ZTSPNa 
Further company coverage:  C4X.PA 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))